European Modular Education and Training Programme in Safety Sciences for Medicines

Knowledge Source Identification
Knowledge source name European Modular Education and Training Programme in Safety Sciences for Medicines
Abbreviated name SafeSciMET
Owner/Developer Innovative Medicines Initiative
Country Belgium
Languages English
Contact email
Description The SafeSciMET programme is established for safety scientists, or others working in drug discovery and development, who want to strengthen their professional area of expertise, including professionals at the start of their industry career. SafeSciMET provides education and training in Safety Sciences leading to a new generation of safety specialists with strong competencies in integrative and translational medicines research and development. The programme also includes application of novel technologies in risk assessment. This will allow holistic and critical evaluations of the safety of drug candidates and new medicines by linking in vitro and in vivo data with patient data more effectively. This programme addresses the needs in small and large pharmaceutical companies, regulatory authorities, academic institutes and health care. The network, bringing together top institutions for drug safety education, training and research with pharmaceutical industry leaders, creates the new type, high quality and sustainable programme. The tailor-made courses encompass safety, ethical, regulatory and societal aspects in all phases of drug development, with emphasis on holistic, integrative, translational and 3Rs aspects of drug safety assessment.
Knowledge Source Category
Category Education/Training
Sub categories Post-graduate program, Training
Knowledge Dissemination and Sharing
Dissemination channel Face-to-face, Website, Professional online network
Targeted audience (specified/objective analysis) Scientists, Students, Industry, Researchers
Users access Fee-based access
Knowledge Characterization
3Rs relevance Replacement, Reduction, Refinement
Purpose Education and training, Documentation and information
Legislative framework Medicines legislation
Technology/Tools Alternative test methods (in vitro), Animal testing (in vivo), Non-testing methods (in silico)